PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $3.70M2011: $3.33M2012: $1.81M2013: $13.38M2014: $994.3K2015: $4.12M2016: $2.14M2017: $13.46M2018: $19.41M2019: $25.55M2020: $30.80M2021: $7.70M2022: $8.27M2023: $9.04M2024: $6.98M2025: $7.00M$7.00M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$7.00M+0.4%
2024$6.98M-22.9%
2023$9.04M+9.4%
2022$8.27M+7.3%
2021$7.70M-75.0%
2020$30.80M+20.5%
2019$25.55M+31.7%
2018$19.41M+44.2%
2017$13.46M+528.2%
2016$2.14M-48.1%
2015$4.12M+314.7%
2014$994.3K-92.6%
2013$13.38M+638.8%
2012$1.81M-45.6%
2011$3.33M-10.1%
2010$3.70M